Companies: 10,795·Total market cap: $144.5T
Myovant Sciences Ltd.

Myovant Sciences Ltd.

MYOVNYSEHealthcare
$26.98
$-0.01(-0.04%)
Market Cap$2.6B
P/E Ratio—
52W High$27.06
52W Low$7.67
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Myovant Sciences Ltd. (MYOV) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001679082 · MYOV · NYSE · as of Jun 8, 2026

Filing snapshot

538
Total Filings
15-12G
Latest Form
2023-03-20
Most Recent
2016
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001679082 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2022-05-11
Fiscal Year End
May 11, 2022
Accession No.
0001679082-22-000071
Primary Document
myov-20220331.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001679082 · Accession 0001679082-22-000071

Latest Key Filings

6-KQuarterly Report

No recent filings

8-KCurrent Report
8-K
2023-03-10Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2023-03-20
View
EFFECTEFFECT
EFFECT
2023-03-16
View
EFFECTEFFECT
EFFECT
2023-03-16
View
25-NSE25-NSE
25-NSE
2023-03-10
View
S-8 POSS-8 POS
S-8 POS
2023-03-10
View
S-8 POSS-8 POS
S-8 POS
2023-03-10
View
S-8 POSS-8 POS
S-8 POS
2023-03-10
View
S-8 POSS-8 POS
S-8 POS
2023-03-10
View
S-8 POSS-8 POS
S-8 POS
2023-03-10
View
S-8 POSS-8 POS
S-8 POS
2023-03-10
View
S-8 POSS-8 POS
S-8 POS
2023-03-10
View
SC 13D/ASC 13D/A
SC 13D/A
2023-03-10
View
POS AMPOS AM
POS AM
2023-03-10
View
POS AMPOS AM
POS AM
2023-03-10
View
SC 13E3/ASC 13E3/A
SC 13E3/A
2023-03-10
View
Showing 1–15 of 292 filingsForm 4 / 144 hidden· 538 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001679082  |  Exchange: NYSE · Healthcare

Myovant Sciences Ltd. (NYSE: MYOV) has submitted 538 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001679082, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Myovant Sciences Ltd.'s most comprehensive regulatory disclosure. The most recent Myovant Sciences Ltd. 10-K was filed on 2022-05-11 for fiscal year ending 2022. Historical MYOV 10-K annual reports are available from 2016 through 2022.

Investors researching Myovant Sciences Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
MOR SEC Filings →SWTX SEC Filings →MORF SEC Filings →KDNY SEC Filings →PRVB SEC Filings →LBPH SEC Filings →DICE SEC Filings →BLU SEC Filings →
→ MYOV Financials→ MYOV Earnings→ MYOV Insider Trades

Frequently Asked Questions

MYOV SEC Filings · 8 questions

Myovant Sciences Ltd. (MYOV) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 538 filings and access original documents at no cost. Myovant Sciences Ltd.'s CIK is 0001679082.

MYOV SEC filingsMyovant Sciences Ltd. SEC documentsfind MYOV 10-K